CompanyGraph
What stands out
- Revenue is growing, but receivables have grown faster over the last six to eight years
At a glance
- Depends onMidstream position: 5 outgoing, 6 incoming connections
- ScaleMarket cap is $2.4B, above the global median of $1.15B
- FinancialsAltman Z-Score 3.39: safe zone
- Interpretations2 currently firing — 2
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
1.36%Above 5Y avg (0.37%)
Annual Rate
JPY 56.00Paid semi-annual
Payout Ratio
9.0%Sustainable
Next Ex-Dividend
Nov 19, 2026
The reported statements, read against the company's own industry.
What stands out
- Revenue is growing, but receivables have grown faster over the last six to eight years
Financials view
Market Capitalization
380.41BJPY2.40B · vs all stocks (USD)
Trailing P/E
22.70xvs Pharmaceutical Retailers peers
Revenue (TTM)
566.86BJPY3.58B · vs all stocks (USD)
Profit Margin
3.02%vs Pharmaceutical Retailers peers
Beta
0.0230xvs all stocks
52-Week Change
-0.27%vs all stocks
Market Capitalization
380.41BJPY2.40B · vs all stocks (USD)
Enterprise Value
472.02BJPY2.98B · vs all stocks (USD)
Trailing P/E
22.70xvs Pharmaceutical Retailers peers
Forward P/E
19.56xvs Pharmaceutical Retailers peers
Price to Sales (TTM)
0.6731xvs Pharmaceutical Retailers peers
Price to Book (MRQ)
2.71xvs Pharmaceutical Retailers peers
Enterprise to Revenue
0.8330xvs Pharmaceutical Retailers peers
Enterprise to EBITDA
11.05xvs Pharmaceutical Retailers peers
Profit Margin
3.02%vs Pharmaceutical Retailers peers
Operating Margin
3.91%vs Pharmaceutical Retailers peers
Return on Assets (TTM)
4.41%vs Pharmaceutical Retailers peers
Return on Equity (TTM)
11.95%vs Pharmaceutical Retailers peers
Revenue (TTM)
566.86BJPY3.58B · vs all stocks (USD)
Revenue per Share (TTM)
5.85KJPYUpdated Aug 20, 2026Quarterly Revenue Growth
11.20%vs Pharmaceutical Retailers peers
Gross Profit (TTM)
149.50BJPY943.57M · vs all stocks (USD)
EBITDA (TTM)
41.34BJPY260.93M · vs all stocks (USD)
Net Income (TTM)
17.13BJPY108.14M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-54.40%vs Pharmaceutical Retailers peers
Operating Cash Flow (TTM)
37.32BJPY235.56M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
257.25MJPY1.62M · vs all stocks (USD)
Trailing Annual Dividend Rate
56.00JPYUpdated Aug 20, 2026Trailing Annual Dividend Yield
1.36%vs all stocks
5-Year Average Dividend Yield
0.37%vs all stocks
Payout Ratio
9.04%vs Pharmaceutical Retailers peers
Revenue
501.47BJPYFY2025 · May 31, 2025Cost of Goods Sold
368.51BJPYFY2025 · May 31, 2025Gross Profit
132.96BJPYFY2025 · May 31, 2025Operating Income
26.60BJPY167.90M · vs all stocks (USD)
Pre-tax Income
25.35BJPYFY2025 · May 31, 2025Income Tax Expense
7.57BJPYFY2025 · May 31, 2025Net Income
17.79BJPYFY2025 · May 31, 2025EBIT
25.97BJPYFY2025 · May 31, 2025EBITDA (Income Statement)
41.34BJPYFY2025 · May 31, 2025Non-operating Interest Income
76.00MJPYFY2025 · May 31, 2025Non-operating Interest Expense
614.00MJPYFY2025 · May 31, 2025EPS (Basic)
175.42JPYFY2025 · May 31, 2025EPS (Diluted)
174.27JPYFY2025 · May 31, 2025Basic Shares Outstanding
101.39MSharesFY2025 · May 31, 2025Diluted Shares Outstanding
101.39MSharesFY2025 · May 31, 2025Preferred Stock Dividends
0.00JPYFY2025 · May 31, 2025Operating Cash Flow
6.52BJPYFY2025 · May 31, 2025Free Cash Flow
-15.14BJPYFY2025 · May 31, 2025Cash & Cash Equivalents (End of Period)
47.73BJPYFY2025 · May 31, 2025Starting Profit (CF Statement)
25.35BJPYFY2025 · May 31, 2025Stock-based Compensation
392.00MJPYFY2025 · May 31, 2025Other Non-cash Items
-1.60BJPYFY2025 · May 31, 2025Change in Accounts Receivable (CF)
-8.83BJPYFY2025 · May 31, 2025Change in Other Assets/Liabilities
-8.80BJPYFY2025 · May 31, 2025Capital Expenditures
-21.66BJPYFY2025 · May 31, 2025Net Intangibles (CF)
-491.00MJPYFY2025 · May 31, 2025Net Acquisitions
-8.87BJPYFY2025 · May 31, 2025Purchase of Investments
-36.00MJPYFY2025 · May 31, 2025Sale of Investments
180.00MJPYFY2025 · May 31, 2025Other Investing Activity
150.00MJPYFY2025 · May 31, 2025Net Investing Cash Flow
-30.23BJPYFY2025 · May 31, 2025Long-term Debt Issuance
25.50BJPYFY2025 · May 31, 2025Long-term Debt Payments
-19.79BJPYFY2025 · May 31, 2025Net Short-term Debt Issuance
-5.50BJPYFY2025 · May 31, 2025Common Stock Repurchase
-12.74BJPYFY2025 · May 31, 2025Common Dividends Paid
-1.25BJPYFY2025 · May 31, 2025Other Financing Charges
-3.00MJPYFY2025 · May 31, 2025Net Financing Cash Flow
10.12BJPYFY2025 · May 31, 2025Shares Outstanding
95.13MSharesUpdated Aug 20, 2026Float Shares
33.07MSharesUpdated Aug 20, 2026% Held by Insiders
55.02%vs all stocks
% Held by Institutions
28.41%vs all stocks
Total Cash (MRQ)
58.93BJPY371.95M · vs all stocks (USD)
Total Cash per Share (MRQ)
620.57JPYUpdated Aug 20, 2026Total Debt (MRQ)
149.77BJPY945.31M · vs all stocks (USD)
Total Debt to Equity (MRQ)
1.06xvs Pharmaceutical Retailers peers
Current Ratio (MRQ)
1.32xvs Pharmaceutical Retailers peers
Book Value per Share (MRQ)
1.49KJPYUpdated Aug 20, 2026Total Assets
352.46BJPY2.22B · vs all stocks (USD)
Total Current Assets
145.37BJPYFY2025 · May 31, 2025Total Liabilities
206.71BJPYFY2025 · May 31, 2025Total Non-current Assets
207.09BJPYFY2025 · May 31, 2025Total Non-current Liabilities
99.66BJPYFY2025 · May 31, 2025Total Current Liabilities
107.05BJPYFY2025 · May 31, 2025Cash & Cash Equivalents
47.73BJPYFY2025 · May 31, 2025Accounts Receivable
21.57BJPYFY2025 · May 31, 2025Inventory
56.81BJPYFY2025 · May 31, 2025Accounts Payable
63.60BJPYFY2025 · May 31, 2025Short-term Debt
14.91BJPYFY2025 · May 31, 2025Other Current Liabilities
6.59BJPYFY2025 · May 31, 2025Long-term Debt
84.41BJPYFY2025 · May 31, 2025Other Non-current Liabilities
529.00MJPYFY2025 · May 31, 2025Common Stock (Book)
16.75BJPYFY2025 · May 31, 2025Retained Earnings
123.01BJPYFY2025 · May 31, 2025Total Shareholders' Equity
145.76BJPY919.96M · vs all stocks (USD)
Treasury Stock
12.75BJPYFY2025 · May 31, 202552-Week Low
3.35KJPYUpdated Aug 20, 202652-Week High
4.82KJPYUpdated Aug 20, 202652-Week Change
-0.27%vs all stocks
Beta
0.0230xvs all stocks
50-Day MA
3.82KJPYUpdated Aug 20, 2026200-Day MA
3.91KJPYUpdated Aug 20, 2026Avg 10-Day Volume
174.02KSharesUpdated Aug 20, 2026Avg 30-Day Volume
224.54KSharesUpdated Aug 20, 2026Diluted EPS (TTM)
177.02JPYUpdated Aug 20, 20262 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsHow does this company use capital?
Industry-Benchmarked ROA and Margin Elevated
Returns and margins have sat in the top of its industry across five years.
Reads
Is this company growing?
Multi-Year Revenue, Profit, And Income Growth
Revenue has risen in each of three years, gross profit in each of four, and it has made a profit in all five.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
Revenue is growing, but receivables have grown faster over the last six to eight yearsSignificant
Revenue Growth YoY: 0.11Receivables vs revenue divergence: 4.43
Financial Health
Altman Z-Score 3.39: safe zoneNotable
Altman Z-Score: 3.39
Supply Chain
Midstream position: 5 outgoing, 6 incoming connectionsNotable
Outgoing: 5.00Incoming: 6.00
High connectivity hub: 11 industry connectionsNotable
Total Connections: 11.00
Scale
Market cap is $2.4B, above the global median of $1.15BNotable
Market cap (USD): 2,401,003,548.529Global Median: 1,146,734,693.424
Revenue is $3.58B, above the global median of $520.53MNotable
Revenue (USD): 3,577,824,942.935Global Median: 520,528,949.311
Companies that share the same coordination system — how they create, deliver, or capture value.
Driven Brands Holdings Inc.
Tier 1FlowUnit ReplicationProductionInterface
Yaoko Co., Ltd.
Tier 1FlowUnit ReplicationInterfaceProduction
Blue Zones Holdings Co., Ltd.
Tier 1FlowUnit ReplicationProductionInterface
Buckle Inc.
Tier 1FlowUnit ReplicationRiskInterface
Migros Ticaret Anonim Sirketi
Tier 1FlowUnit ReplicationInterfaceProduction
Topsports International Holdings Limited
Tier 1FlowUnit ReplicationRiskInterface
Ocado Group Plc
Tier 1FlowUnit ReplicationInterfaceProduction
Transportation Telecommunications Inc.
Tier 1FlowUnit ReplicationInterfaceProduction
Sendas Distribuidora S.A.
Tier 1FlowUnit ReplicationProductionInterface
Metro Brands Ltd.
Tier 1FlowUnit ReplicationRiskInterface
Companies that share active interpretations — structural patterns currently present in both stocks.
Donglai Coating Technology Co., Ltd.
2 interpretationsIndustry-Benchmarked ROA and Margin ElevatedMulti-Year Revenue, Profit, And Income Growth
CSW Industrials Inc.
2 interpretationsIndustry-Benchmarked ROA and Margin ElevatedMulti-Year Revenue, Profit, And Income Growth
Cyrela Brazil Realty S.A. Empreendimentos e Participações
2 interpretationsIndustry-Benchmarked ROA and Margin ElevatedMulti-Year Revenue, Profit, And Income Growth